Industry Reports

Custom Research

About

Knowledge Center

Contact

Global Drug screening Market Assessment, By Components [Rapid Testing Devices, Equipment, Consumables, Laboratory Services], By Sample Type [Breath, Oral Fluid, Hair, Urine, Others], By End-user [Hospital, Workplaces, Drug Testing Laboratories, Criminal Justice System and Law Enforcement Agencies, Others], By Region, Opportunities and Forecast, 2017-2031F

Q: Who are the key players operating in the global drug screening market?

The key players operating in the global drug screening market are Abbott Laboratories, Alfa Scientific Designs Inc., Bio-Rad Laboratories, Inc., Dräger Group, Thermo Fisher Scientific, Siemens Healthineers company, Psychemedics Corporation, OraSure Technologies, Inc., Omega Laboratories, Inc., and Laboratory Corporation of America Holdings.

Q: What are the regions covered in the final report for the global drug screening market?

The regions covered in the final report of the global drug screening market are North America, Europe, Asia-Pacific, South America, and Middle East and Africa.

Q: What are the major drivers influencing the growth of the global drug screening market?

The major factors influencing the global drug screening market growth are the increasing number of drug abuse worldwide, technological advancements, and growing medical and diagnostics industry. Increased investments, research and development activities, and collaborative ventures are further escalating the market demand.

Q: What is the market size and growth rate of the global drug screening market?

Global drug screening market size was valued at USD 7.02 billion in 2023, which is expected to grow to USD 20.96 billion in 2031, with a CAGR of 14.65% for the forecast period between 2024 and 2031.

The global drug screening market is being driven by an increasing prevalence of drug abuse worldwide, technological advancements, increased investments by public and private organizations, and research and development activities, along with governmental initiatives and support.

Home>Industry Reports>Global Drug screening Market Assessment, Opportunities and Forecast, 2017-2031F

Global drug screening market is projected to witness a CAGR of 14.65% during the forecast period 2024-2031, growing from USD 7.02 billion in 2023 to USD 20.96 billion in 2031. Growth in the global drug screening market is driven by various factors, such as increasing alcohol and drug consumption, technological advancements in drug testing products, and increased implementation of strict rules and regulations regarding proper drug screening among the people to maintain discipline and safety measures. Growing investments in research and development activities, presence of several top players, and collaborative ventures, such as mergers and acquisitions, partnerships, distribution agreements, and frequent new product launches, further accelerate the growth of the global drug screening market.

The global drug screening market is experiencing tremendous growth due to various key factors. One of the primary drivers is the increasing global consumption of drugs and alcohol, leading to an increased demand for drug screening services worldwide. Stringent regulations frameworks to enhance drug and alcohol testing are fueling the market's expansion. Additionally, excessive drug abuse leads to a rising burden of accidents, which has further accelerated the need for developing effective drug screening solutions. Government initiatives and support, such as granting funds, to manage and monitor drug abuse play a pivotal role in propelling market growth. The presence of key market players, along with continuous technological advancements in drug screening products, are enhancing their efficiency and effectiveness, thereby driving demand for more advanced solutions. Moreover, collaboration activities, such as mergers and acquisitions, distribution agreements, and partnerships, further accelerate growth of the global drug screening market.

For instance, in January 2024, OraSure Technologies, Inc., which is a global leader in diagnostics, announced that it has signed a distribution agreement with Sapphiros, which is a Boston-based diagnostics company. Through this strategic partnership, OraSure expects to develop cost-effective diagnostics tests and enhance its product portfolio, as well as expand its business globally.

Increasing Consumption of Psychoactive Substances

The increased consumption of drugs and alcohol is accelerating the drug screening market. Anxiety, stress, depression, isolation, and limited access to social help have contributed to higher drug abuse among the population. Rising cases of drug overdose, which leads to many adverse effects, such as accidents, self-destruction activities, and even death, have surged the need for drug screening services. For instance, according to World Drug Report 2023, the total number of drug users in the year 2021 was estimated to be 296 million. It is also estimated that cannabis is the most widely used drug by the population across the globe. This increasing drug abuse led to the global burden on health and health-care systems, emphasizing the importance of following strict drug screening activities. Additionally, drug screening plays an essential role in minimizing the growing cases of accidents, such as road traffic accidents, which is acting as a major factor flourishing the market growth.

Government Initiatives

The government plays a crucial role in managing and controlling the increased prevalence of drug abuse by continuously developing policies and programs to monitor drug abuse cases within the country. The government is involved in promoting research and development activities to develop highly efficient drug abuse detection products and devices. For instance, the National Institute on Drug Abuse, which is a federal agency that works on supporting scientific research on understanding and controlling drug abuse, emphasizes on promoting research and development activities to control global drug abuse. The federal agency brings concerns on various aspects of drug abuse, such as developing drug testing kits that can efficiently and accurately detect alcohol and drug consumption. Due to these frequent governmental support and initiatives, public and private diagnostics companies are excessively involved in developing innovative drug screening products and have increased investment activities, which is further improving the overall global drug screening market.

Increased Demand for Rapid Testing Devices

Among the component segment, rapid testing devices are gaining popularity, due to which this segment is expected to grow at a faster pace in the global drug screening market. These devices are easy to administer, are cost-effective, and give faster results due to which they are excessively used in the market. As the demand is rising, several leading players are launching this product in their product portfolio. For instance, in April 2023, MIP Discovery, which is a pioneer in developing reagents, announced the launch of “Novel nanoMIPTM affinity reagents” using its proprietary nanoMIPTM technology to detect opioid. This reagent is highly sensitive and robust in detecting opioid consumption. These latest launches by key companies in this segment are expected to enhance growth in the global drug screening market.

Growing Demand for Oral Fluid Samples-based Testing Kits

Among the sample type segment, oral fluids, such as saliva-based samples, are expected to show significant growth in the future. There have been increased investments and research and development activities to develop oral fluid sample-based diagnostics kits by several leading players, which is accelerating market growth. For instance, Alfa Scientific Designs Inc., which is a global leader in the development and manufacturing of rapid immunoassay point-of-care tests, states in its latest article that saliva testing has gained tremendous growth over the past few years. Several rapid diagnostic test manufacturers have claimed that saliva samples give faster results compared to other samples. Additionally, saliva samples possess several benefits over other samples as they can be done anywhere, anytime, do not require other tools and appliances for data collection, and do not have any privacy issue. Due to these potential benefits of saliva-based tests, several leading players prefer to invest in developing diagnostics kits that use saliva samples to detect drug abuse, further enhancing their product portfolio and leading to the growth of global drug screening market.

North America Holds the Maximum Share in the Market

North America dominates the global drug screening market due to its robust healthcare system and implementation of strict rules and regulations regarding drug abuse. The availability of technologically advanced drug screening kits and their high efficiency in detecting drug usage further propels the drug screening market in the region. Additionally, the increasing prevalence of drug abuse in the United States is compelling the requirement for efficient drug screening products, thereby significantly impacting the market growth. For instance, according to the U.S. National Center for Drug Abuse Statistics, around 19.4% of U.S population have used illegal drugs at least once in the year 2021. Additionally, The Journal of the American Medical Association report also states that between January 2021 and June 2021, approximately 1,150 youngsters within the age group of 14 to 18 died from drug overdose. Due to this increasing number of people involved in excessive drug and alcohol consumption, there has been a substantial need for drug screening activities to combat the increasing number of drug abuse cases in the region.

Future Market Scenario (2024 – 2031F)

The global drug screening market is expected to grow in the future, primarily due to increased global consumption of drugs and alcohol, stringent rules and regulations on drug testing, and government initiatives and support to combat drug abuse. Additionally, technological advancements and increased investments by public and private diagnostics manufacturers will lead to the development of more efficient drug screening products, thereby creating lucrative market opportunities. Moreover, favorable regulatory frameworks that help in faster FDA approvals, while maintaining the accuracy and efficacy of the drug testing devices, further accelerate the growth of the global drug screening market.

Report Scope

“Drug screening Market Assessment, Opportunities, and Forecast, 2017-2031F”, is a comprehensive report by Markets and Data, providing in-depth analysis and qualitative and quantitative assessment of the current state of the global drug screening market, industry dynamics, and challenges. The report includes market size, segmental shares, growth trends, opportunities, and forecast between 2024 and 2031. Additionally, the report profiles the leading players in the industry mentioning their respective market share, business model, competitive intelligence, etc.

Report Attribute	Details
Base Year of the Analysis	2023
Historical Period	2017-2022
Forecast Period	2024-2031
Projected Growth Rate	CAGR of 14.65% between 2024 and 2031
Revenue Forecast in 2031	USD 20.96 billion
Segments Covered	Components, Sample Type, End-user
Regions Covered	North America, Europe, South America, Asia-Pacific, Middle East and Africa
Key Companies Profile	Abbott Laboratories, Alfa Scientific Designs Inc., Bio-Rad Laboratories, Inc., Dräger Group, Thermo Fisher Scientific, Siemens Healthineers company, Psychemedics Corporation, OraSure Technologies, Inc., Omega Laboratories, Inc., Laboratory Corporation of America Holdings
Customization Scope	15% free report customization with purchase
Pricing and Purchase Options	Avail the customized purchase options to fulfill your precise research needs
Delivery Format	PDF and Excel through email (subject to the license purchased)

In this report, the global drug screening market has been segmented into the following categories:

· By Components

o Rapid Testing Devices

§ Urine Testing Devices

§ Oral Fluid Testing Devices

o Equipment

§ Breath Analyzers

§ Immunoassay Analyzers

§ Chromatography Instruments

o Consumables

§ Assay Kits

§ Sample Collection Cups

§ Calibrators and Controls

§ Others

o Laboratory Services

· By Sample Type

o Breath

o Oral Fluid

o Hair

o Urine

o Others

· By End-user

o Hospital

o Workplaces

o Drug Testing Laboratories

o Criminal Justice System and Law Enforcement Agencies

o Others

· By Region

o North America

o Europe

o Asia-Pacific

o South America

o Middle East and Africa

Key Players Landscape and Outlook

In the drug screening market, several leading players are frequently undergoing strategic partnerships and distribution agreements, which play a pivotal role in propelling the global drug screening market's expansion. These partnership agreements empower companies to gain informative insights regarding the latest trends in the market, access each other’s resources, and technologies, and invest in research and development activities to enhance and innovate product offerings. Distribution agreements enable companies to broaden their market presence at a global level. These collaborative initiatives promote innovation, expertise product development, and contribute to the enduring and tremendous growth of the global market. For instance, in February 2023, Omega Laboratories, which is a global leader in providing laboratory testing solutions, announced that it has established a strategic partnership with Life Diagnostics, which is among the UAE’s fastest-growing company in diagnostics. This partnership aims to establish a new drugs of abuse testing laboratory in the country, which is expected to lead the growth of the Middle East and Africa region in the global drug screening market.

Key Players Operating in the Global Drug Screening Market are:

· Abbott Laboratories

· Alfa Scientific Designs Inc.

· Bio-Rad Laboratories, Inc.

· Dräger Group

· Thermo Fisher Scientific

· Siemens Healthineers company

· Psychemedics Corporation

· OraSure Technologies, Inc.

· Omega Laboratories, Inc.

· Laboratory Corporation of America Holdings

Markets and Data’s reports answer the following questions:

· What is the current and future market size of the product/service in question globally or specific to different countries?

· How are the markets divided into different product/service segments and the market size and growth of each segment?

· What is the market potential of different product segments and their investment case?

· How are the markets predicted to develop in the future and what factors will drive or inhibit growth?

· What is the business environment and regulatory landscape specific to the product/service?

If you can't find what you're searching for or have any custom requirements for the global drug screening market, you may approach our team at info@marketsandata.com

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Executive Summary

4. Global Drug Screening Market Outlook, 2017-2031F

4.1. Market Size & Forecast

4.1.1.By Value

4.1.2.By Volume

4.2. By Components

4.2.1.Rapid Testing Devices

4.2.1.1. Urine Testing Devices

4.2.1.2. Oral Fluid Testing Devices

4.2.2.Equipment

4.2.2.1. Breath Analyzers

4.2.2.2. Immunoassay Analyzers

4.2.2.3. Chromatography Instruments

4.2.3.Consumables

4.2.3.1. Assay Kits

4.2.3.2. Sample Collection Cups

4.2.3.3. Calibrators and Controls

4.2.3.4. Others

4.2.4.Laboratory Services

4.3. By Sample Type

4.3.1.Breath

4.3.2.Oral Fluid

4.3.3.Hair

4.3.4.Urine

4.3.5.Others

4.4. By End-user

4.4.1.Hospital

4.4.2.Workplaces

4.4.3.Drug Testing Laboratories

4.4.4.Criminal Justice System and Law Enforcement Agencies

4.4.5.Others

4.5. By Region

4.5.1. North America

4.5.2. Europe

4.5.3. Asia-Pacific

4.5.4. South America

4.5.5. Middle East and Africa

4.6. By Company Market Share (%), 2023

5. Global Drug screening Market Outlook, By Region, 2017-2031F

5.1. North America*

5.1.1.Market Size & Forecast

5.1.1.1. By Value

5.1.1.2. By Volume

5.1.2.By Components

5.1.2.1. Rapid Testing Devices

5.1.2.1.1. Urine Testing Devices

5.1.2.1.2. Oral Fluid Testing Devices

5.1.2.2. Equipment

5.1.2.2.1. Breath Analyzers

5.1.2.2.2. Immunoassay Analyzers

5.1.2.2.3. Chromatography Instruments

5.1.2.3. Consumables

5.1.2.3.1. Assay Kits

5.1.2.3.2. Sample Collection Cups

5.1.2.3.3. Calibrators and Controls

5.1.2.3.4. Others

5.1.2.4. Laboratory Services

5.1.3.By Sample Type

5.1.3.1. Breath

5.1.3.2. Oral Fluid

5.1.3.3. Hair

5.1.3.4. Urine

5.1.3.5. Others

5.1.4.By End-user

5.1.4.1. Hospital

5.1.4.2. Workplaces

5.1.4.3. Drug Testing Laboratories

5.1.4.4. Criminal Justice System and Law Enforcement Agencies

5.1.4.5. Others

5.1.5.United States*

5.1.5.1. Market Size & Forecast

5.1.5.1.1. By Value

5.1.5.1.2. By Volume

5.1.5.2. By Components

5.1.5.2.1. Rapid Testing Devices

5.1.5.2.1.1. Rapid Testing Devices

5.1.5.2.1.2. Urine Testing Devices

5.1.5.2.1.3. Oral Fluid Testing Devices

5.1.5.2.2. Equipment

5.1.5.2.2.1. Breath Analyzers

5.1.5.2.2.2. Immunoassay Analyzers

5.1.5.2.2.3. Chromatography Instruments

5.1.5.2.3. Consumables

5.1.5.2.3.1. Assay Kits

5.1.5.2.3.2. Sample Collection Cups

5.1.5.2.3.3. Calibrators and Controls

5.1.5.2.3.4. Others

5.1.5.2.4. Laboratory Services

5.1.5.3. By Sample Type

5.1.5.3.1. Breath

5.1.5.3.2. Oral Fluid

5.1.5.3.3. Hair

5.1.5.3.4. Urine

5.1.5.3.5. Others

5.1.5.4. By End-user

5.1.5.4.1. Hospital

5.1.5.4.2. Workplaces

5.1.5.4.3. Drug Testing Laboratories

5.1.5.4.4. Criminal Justice System and Law Enforcement Agencies

5.1.5.4.5. Others

5.1.6.Canada

5.1.7.Mexico

*All segments will be provided for all regions and countries covered

5.2. Europe

5.2.1.Germany

5.2.2.France

5.2.3.Italy

5.2.4.United Kingdom

5.2.5.Russia

5.2.6.Netherlands

5.2.7.Spain

5.2.8.Turkey

5.2.9.Poland

5.3. Asia-Pacific

5.3.1.India

5.3.2.China

5.3.3.Japan

5.3.4.Australia

5.3.5.Vietnam

5.3.6.South Korea

5.3.7.Indonesia

5.3.8.Philippines

5.4. South America

5.4.1.Brazil

5.4.2.Argentina

5.5. Middle East & Africa

5.5.1.Saudi Arabia

5.5.2.UAE

5.5.3.South Africa

6. Market Mapping, 2023

6.1. By Components

6.2. By Sample Type

6.3. By End-user

6.4. By Region

7. Macro Environment and Industry Structure

7.1. Demand Supply Analysis

7.2. Import Export Analysis

7.3. Value Chain Analysis

7.4. PESTEL Analysis

7.4.1.Political Factors

7.4.2.Economic System

7.4.3.Social Implications

7.4.4.Technological Advancements

7.4.5.Environmental Impacts

7.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)

7.5. Porter’s Five Forces Analysis

7.5.1.Supplier Power

7.5.2.Buyer Power

7.5.3.Substitution Threat

7.5.4.Threat from New Entrant

7.5.5.Competitive Rivalry

8. Market Dynamics

8.1. Growth Drivers

8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

9.1. Patent Landscape

9.2. Innovations/Emerging Technologies

10. Key Players Landscape

10.1. Competition Matrix of Top Five Market Leaders

10.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)

10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)

10.4. SWOT Analysis (For Five Market Players)

10.5. Patent Analysis (If Applicable)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

13.1. Abbott Laboratories

13.1.1. Company Details

13.1.2. Key Management Personnel

13.1.3. Products & Services

13.1.4. Financials (As reported)

13.1.5. Key Market Focus & Geographical Presence

13.1.6. Recent Developments

13.2. Alfa Scientific Designs Inc.

13.3. Bio-Rad Laboratories, Inc.

13.4. Dräger Group

13.5. Thermo Fisher Scientific

13.6. Siemens Healthineers company

13.7. Psychemedics Corporation

13.8. OraSure Technologies, Inc.

13.9. Omega Laboratories, Inc.

13.10. Laboratory Corporation of America Holdings

*Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

14. Strategic Recommendations

15. About Us & Disclaimer

List of Figures

Figure 1. Global Drug Screening Market, By Value, in USD Billion, 2017-2031F

Figure 2. Global Drug Screening Market, By Volume, in Million Units, 2017-2031F

Figure 3. Global Drug Screening Market Share (%), By Components, 2017-2031F

Figure 4. Global Drug Screening Market Share (%), By Sample Type, 2017-2031F

Figure 5. Global Drug Screening Market Share (%), By End-user, 2017-2031F

Figure 6. Global Drug Screening Market Share (%), By Region, 2017-2031F

Figure 7. North America Drug Screening Market, By Value, in USD Billion, 2017-2031F

Figure 8. North America Drug Screening Market, By Volume, in Million Units, 2017-2031F

Figure 9. North America Drug Screening Market Share (%), By Components, 2017-2031F

Figure 10. North America Drug Screening Market Share (%), By Sample Type, 2017-2031F

Figure 11. North America Drug Screening Market Share (%), By End-user, 2017-2031F

Figure 12. North America Drug Screening Market Share (%), By Country, 2017-2031F

Figure 13. United States Drug Screening Market, By Value, in USD Billion, 2017-2031F

Figure 14. United States Drug Screening Market, By Volume, in Million Units, 2017-2031F

Figure 15. United States Drug Screening Market Share (%), By Components, 2017-2031F

Figure 16. United States Drug Screening Market Share (%), By Sample Type, 2017-2031F

Figure 17. United States Drug Screening Market Share (%), By End-user, 2017-2031F

Figure 18. Canada Drug Screening Market, By Value, in USD Billion, 2017-2031F

Figure 19. Canada Drug Screening Market, By Volume, in Million Units, 2017-2031F

Figure 20. Canada Drug Screening Market Share (%), By Components, 2017-2031F

Figure 21. Canada Drug Screening Market Share (%), By Sample Type, 2017-2031F

Figure 22. Canada Drug Screening Market Share (%), By End-user, 2017-2031F

Figure 23. Mexico Drug Screening Market, By Value, in USD Billion, 2017-2031F

Figure 24. Mexico Drug Screening Market, By Volume, in Million Units, 2017-2031F

Figure 25. Mexico Drug Screening Market Share (%), By Components, 2017-2031F

Figure 26. Mexico Drug Screening Market Share (%), By Sample Type, 2017-2031F

Figure 27. Mexico Drug Screening Market Share (%), By End-user, 2017-2031F

Figure 28. Europe Drug Screening Market, By Value, in USD Billion, 2017-2031F

Figure 29. Europe Drug Screening Market, By Volume, in Million Units, 2017-2031F

Figure 30. Europe Drug Screening Market Share (%), By Components, 2017-2031F

Figure 31. Europe Drug Screening Market Share (%), By Sample Type, 2017-2031F

Figure 32. Europe Drug Screening Market Share (%), By End-user, 2017-2031F

Figure 33. Europe Drug Screening Market Share (%), By Country, 2017-2031F

Figure 34. Germany Drug Screening Market, By Value, in USD Billion, 2017-2031F

Figure 35. Germany Drug Screening Market, By Volume, in Million Units, 2017-2031F

Figure 36. Germany Drug Screening Market Share (%), By Components, 2017-2031F

Figure 37. Germany Drug Screening Market Share (%), By Sample Type, 2017-2031F

Figure 38. Germany Drug Screening Market Share (%), By End-user, 2017-2031F

Figure 39. France Drug Screening Market, By Value, in USD Billion, 2017-2031F

Figure 40. France Drug Screening Market, By Volume, in Million Units, 2017-2031F

Figure 41. France Drug Screening Market Share (%), By Components, 2017-2031F

Figure 42. France Drug Screening Market Share (%), By Sample Type, 2017-2031F

Figure 43. France Drug Screening Market Share (%), By End-user, 2017-2031F

Figure 44. Italy Drug Screening Market, By Value, in USD Billion, 2017-2031F

Figure 45. Italy Drug Screening Market, By Volume, in Million Units, 2017-2031F

Figure 46. Italy Drug Screening Market Share (%), By Components, 2017-2031F

Figure 47. Italy Drug Screening Market Share (%), By Sample Type, 2017-2031F

Figure 48. Italy Drug Screening Market Share (%), By End-user, 2017-2031F

Figure 49. United Kingdom Drug Screening Market, By Value, in USD Billion, 2017-2031F

Figure 50. United Kingdom Drug Screening Market, By Volume, in Million Units, 2017-2031F

Figure 51. United Kingdom Drug Screening Market Share (%), By Components, 2017-2031F

Figure 52. United Kingdom Drug Screening Market Share (%), By Sample Type, 2017-2031F

Figure 53. United Kingdom Drug Screening Market Share (%), By End-user, 2017-2031F

Figure 54. Russia Drug Screening Market, By Value, in USD Billion, 2017-2031F

Figure 55. Russia Drug Screening Market, By Volume, in Million Units, 2017-2031F

Figure 56. Russia Drug Screening Market Share (%), By Components, 2017-2031F

Figure 57. Russia Drug Screening Market Share (%), By Sample Type, 2017-2031F

Figure 58. Russia Drug Screening Market Share (%), By End-user, 2017-2031F

Figure 59. Netherlands Drug Screening Market, By Value, in USD Billion, 2017-2031F

Figure 60. Netherlands Drug Screening Market, By Volume, in Million Units, 2017-2031F

Figure 61. Netherlands Drug Screening Market Share (%), By Components, 2017-2031F

Figure 62. Netherlands Drug Screening Market Share (%), By Sample Type, 2017-2031F

Figure 63. Netherlands Drug Screening Market Share (%), By End-user, 2017-2031F

Figure 64. Spain Drug Screening Market, By Value, in USD Billion, 2017-2031F

Figure 65. Spain Drug Screening Market, By Volume, in Million Units, 2017-2031F

Figure 66. Spain Drug Screening Market Share (%), By Components, 2017-2031F

Figure 67. Spain Drug Screening Market Share (%), By Sample Type, 2017-2031F

Figure 68. Spain Drug Screening Market Share (%), By End-user, 2017-2031F

Figure 69. Turkey Drug Screening Market, By Value, in USD Billion, 2017-2031F

Figure 70. Turkey Drug Screening Market, By Volume, in Million Units, 2017-2031F

Figure 71. Turkey Drug Screening Market Share (%), By Components, 2017-2031F

Figure 72. Turkey Drug Screening Market Share (%), By Sample Type, 2017-2031F

Figure 73. Turkey Drug Screening Market Share (%), By End-user, 2017-2031F

Figure 74. Poland Drug Screening Market, By Value, in USD Billion, 2017-2031F

Figure 75. Poland Drug Screening Market, By Volume, in Million Units, 2017-2031F

Figure 76. Poland Drug Screening Market Share (%), By Components, 2017-2031F

Figure 77. Poland Drug Screening Market Share (%), By Sample Type, 2017-2031F

Figure 78. Poland Drug Screening Market Share (%), By End-user, 2017-2031F

Figure 79. South America Drug Screening Market, By Value, in USD Billion, 2017-2031F

Figure 80. South America Drug Screening Market, By Volume, in Million Units, 2017-2031F

Figure 81. South America Drug Screening Market Share (%), By Components, 2017-2031F

Figure 82. South America Drug Screening Market Share (%), By Sample Type, 2017-2031F

Figure 83. South America Drug Screening Market Share (%), By End-user, 2017-2031F

Figure 84. South America Drug Screening Market Share (%), By Country, 2017-2031F

Figure 85. Brazil Drug Screening Market, By Value, in USD Billion, 2017-2031F

Figure 86. Brazil Drug Screening Market, By Volume, in Million Units, 2017-2031F

Figure 87. Brazil Drug Screening Market Share (%), By Components, 2017-2031F

Figure 88. Brazil Drug Screening Market Share (%), By Sample Type, 2017-2031F

Figure 89. Brazil Drug Screening Market Share (%), By End-user, 2017-2031F

Figure 90. Argentina Drug Screening Market, By Value, in USD Billion, 2017-2031F

Figure 91. Argentina Drug Screening Market, By Volume, in Million Units, 2017-2031F

Figure 92. Argentina Drug Screening Market Share (%), By Components, 2017-2031F

Figure 93. Argentina Drug Screening Market Share (%), By Sample Type, 2017-2031F

Figure 94. Argentina Drug Screening Market Share (%), By End-user, 2017-2031F

Figure 95. Asia-Pacific Drug Screening Market, By Value, in USD Billion, 2017-2031F

Figure 96. Asia-Pacific Drug Screening Market, By Volume, in Million Units, 2017-2031F

Figure 97. Asia-Pacific Drug Screening Market Share (%), By Components, 2017-2031F

Figure 98. Asia-Pacific Drug Screening Market Share (%), By Sample Type, 2017-2031F

Figure 99. Asia-Pacific Drug Screening Market Share (%), By End-user, 2017-2031F

Figure 100. Asia-Pacific Drug Screening Market Share (%), By Country, 2017-2031F

Figure 101. India Drug Screening Market, By Value, in USD Billion, 2017-2031F

Figure 102. India Drug Screening Market, By Volume, in Million Units, 2017-2031F

Figure 103. India Drug Screening Market Share (%), By Components, 2017-2031F

Figure 104. India Drug Screening Market Share (%), By Sample Type, 2017-2031F

Figure 105. India Drug Screening Market Share (%), By End-user, 2017-2031F

Figure 106. China Drug Screening Market, By Value, in USD Billion, 2017-2031F

Figure 107. China Drug Screening Market, By Volume, in Million Units, 2017-2031F

Figure 108. China Drug Screening Market Share (%), By Components, 2017-2031F

Figure 109. China Drug Screening Market Share (%), By Sample Type, 2017-2031F

Figure 110. China Drug Screening Market Share (%), By End-user, 2017-2031F

Figure 111. Japan Drug Screening Market, By Value, in USD Billion, 2017-2031F

Figure 112. Japan Drug Screening Market, By Volume, in Million Units, 2017-2031F

Figure 113. Japan Drug Screening Market Share (%), By Components, 2017-2031F

Figure 114. Japan Drug Screening Market Share (%), By Sample Type, 2017-2031F

Figure 115. Japan Drug Screening Market Share (%), By End-user, 2017-2031F

Figure 116. Australia Drug Screening Market, By Value, in USD Billion, 2017-2031F

Figure 117. Australia Drug Screening Market, By Volume, in Million Units, 2017-2031F

Figure 118. Australia Drug Screening Market Share (%), By Components, 2017-2031F

Figure 119. Australia Drug Screening Market Share (%), By Sample Type, 2017-2031F

Figure 120. Australia Drug Screening Market Share (%), By End-user, 2017-2031F

Figure 121. Vietnam Drug Screening Market, By Value, in USD Billion, 2017-2031F

Figure 122. Vietnam Drug Screening Market, By Volume, in Million Units, 2017-2031F

Figure 123. Vietnam Drug Screening Market Share (%), By Components, 2017-2031F

Figure 124. Vietnam Drug Screening Market Share (%), By Sample Type, 2017-2031F

Figure 125. Vietnam Drug Screening Market Share (%), By End-user, 2017-2031F

Figure 126. South Korea Drug Screening Market, By Value, in USD Billion, 2017-2031F

Figure 127. South Korea Drug Screening Market, By Volume, in Million Units, 2017-2031F

Figure 128. South Korea Drug Screening Market Share (%), By Components, 2017-2031F

Figure 129. South Korea Drug Screening Market Share (%), By Sample Type, 2017-2031F

Figure 130. South Korea Drug Screening Market Share (%), By End-user, 2017-2031F

Figure 131. Indonesia Drug Screening Market, By Value, in USD Billion, 2017-2031F

Figure 132. Indonesia Drug Screening Market, By Volume, in Million Units, 2017-2031F

Figure 133. Indonesia Drug Screening Market Share (%), By Components, 2017-2031F

Figure 134. Indonesia Drug Screening Market Share (%), By Sample Type, 2017-2031F

Figure 135. Indonesia Drug Screening Market Share (%), By End-user, 2017-2031F

Figure 136. Philippines Drug Screening Market, By Value, in USD Billion, 2017-2031F

Figure 137. Philippines Drug Screening Market, By Volume, in Million Units, 2017-2031F

Figure 138. Philippines Drug Screening Market Share (%), By Components, 2017-2031F

Figure 139. Philippines Drug Screening Market Share (%), By Sample Type, 2017-2031F

Figure 140. Philippines Drug Screening Market Share (%), By End-user, 2017-2031F

Figure 141. Middle East & Africa Drug Screening Market, By Value, in USD Billion, 2017-2031F

Figure 142. Middle East & Africa Drug Screening Market, By Volume, in Million Units, 2017-2031F

Figure 143. Middle East & Africa Drug Screening Market Share (%), By Components, 2017-2031F

Figure 144. Middle East & Africa Drug Screening Market Share (%), By Sample Type, 2017-2031F

Figure 145. Middle East & Africa Drug Screening Market Share (%), By End-user, 2017-2031F

Figure 146. Middle East & Africa Drug Screening Market Share (%), By Country, 2017-2031F

Figure 147. Saudi Arabia Drug Screening Market, By Value, in USD Billion, 2017-2031F

Figure 148. Saudi Arabia Drug Screening Market, By Volume, in Million Units, 2017-2031F

Figure 149. Saudi Arabia Drug Screening Market Share (%), By Components, 2017-2031F

Figure 150. Saudi Arabia Drug Screening Market Share (%), By Sample Type, 2017-2031F

Figure 151. Saudi Arabia Drug Screening Market Share (%), By End-user, 2017-2031F

Figure 152. UAE Drug Screening Market, By Value, in USD Billion, 2017-2031F

Figure 153. UAE Drug Screening Market, By Volume, in Million Units, 2017-2031F

Figure 154. UAE Drug Screening Market Share (%), By Components, 2017-2031F

Figure 155. UAE Drug Screening Market Share (%), By Sample Type, 2017-2031F

Figure 156. UAE Drug Screening Market Share (%), By End-user, 2017-2031F

Figure 157. South Africa Drug Screening Market, By Value, in USD Billion, 2017-2031F

Figure 158. South Africa Drug Screening Market, By Volume, in Million Units, 2017-2031F

Figure 159. South Africa Drug Screening Market Share (%), By Components, 2017-2031F

Figure 160. South Africa Drug Screening Market Share (%), By Sample Type, 2017-2031F

Figure 161. South Africa Drug Screening Market Share (%), By End-user, 2017-2031F

Figure 162. By Components Map-Market Size (USD Billion) & Growth Rate (%), 2023

Figure 163. By Sample Type Map-Market Size (USD Billion) & Growth Rate (%), 2023

Figure 164. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023

Figure 165. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023

List of Tables

Table 1. Pricing Analysis of Products from Key Players

Table 2. Competition Matrix of Top 5 Market Leaders

Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)

Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

Frequently Asked Questions

Who are the key players operating in the global drug screening market?

What are the regions covered in the final report for the global drug screening market?

What are the major drivers influencing the growth of the global drug screening market?

What is the market size and growth rate of the global drug screening market?

See Related Reports

View ALL

Global Bone Densitometers Market Assessment, Opportunities and Forecast, 2017-2031F

There is an increased demand for dual-energy x-ray absorptiometry (DXA) in the global bone densitometers market. Also, increasing prevalence of osteoporosis, growing geriatric population, technological advancements, and collaborative research and new....Read More

Published on

May 2024

4,500

Global Medical Terminology Software Market Assessment, Opportunities and Forecast, 2017-2031F

Global medical terminology software market is expected to witness significant growth over the forecast period owing to an increase in measures for reducing clinical errors and rising investments towards the development of technologically advanced sol....Read More

Published on

May 2024

4,500

Global Legionella Testing Market Assessment, Opportunities and Forecast, 2017-2031F

Global legionella testing market will witness significant growth owing to the rapid expansion of the healthcare sector, increasing awareness about the importance of regular legionella testing, and rising prevalence of legionella related illnesses.....Read More

Published on

May 2024

4,500

Global Endoluminal Suturing Devices Market Assessment, Opportunities and Forecast, 2017-2031F

Global endoluminal suturing devices market is expected to witness significant growth over the forecast period owing to rise in the number of cases of gastrointestinal cancer and increasing preference for non-invasive procedures.....Read More

Published on

May 2024

4,500

Purchase Options

USD ($)